ECDC and EMA make joint statement on updating COVID-19 vaccines

The currently licensed COVID-19 vaccines in the European Union (EU) include the following variants: Wuhan monovalent (original vaccine), bivalent Wuhan/Omicron BA.1, bivalent Wuhan/Omicron BA.4/5, monovalent Beta(B.1.351) and bivalent Beta (B.1.351) Alpha (B.1.1.7).

The available efficacy and effectiveness data show that the currently approved COVID-19 vaccines continue to provide protection against severe illness, hospitalization and death. However, the same data indicate that protection decreases with time and as the virus mutates. Read more here

ELS can and is able to register all types of medicines in Europe and LATAM, as well as ensure their distribution and assist in the research and development of new medicines.

Please contact your ELS local consultant or through the email: info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.